Mesenchymal Stem Cell Derived Exosomes Therapy in Diabetic Wound Repair
DOI: https://doi.org/10.2147/IJN.S411562
IF: 7.033
2023-05-22
International Journal of Nanomedicine
Abstract:Shengyu Jing, 1, 2 Hongjie Li, 1, 2 Hongbo Xu 1 1 Department of Vascular Surgery, The Third Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China; 2 Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China Correspondence: Hongbo Xu, Department of Vascular Surgery, The Third Xiangya Hospital of Central South University, Changsha, Hunan, 410013, People's Republic of China, Tel +86 13973112593, Fax +86 73188618034, Email Nowadays, refractory diabetic wounds cause a worldwide medical burden. Mesenchymal stem cells derived exosomes (MSC-Exos) show promise as a solid alternative to existing therapeutics in the latest researches, since MSC-Exos share similar biologic activity but less immunogenicity when compared with MSCs. To facilitate further understanding and application, it is essential to summarize the current progress and limitations of MSC-Exos in the treatment of diabetic wounds. In this review, we introduce the effects of different MSC-Exos on diabetic wounds according to their origins and contents and discuss the specific experimental conditions, target wound cells/pathways, and specific mechanisms. In addition, this paper focuses on the combination of MSC-Exos and biomaterials, which improves the efficacy and utilization of MSC-Exos therapy. Together, exosome therapy has high clinical value and application prospects, both in its role and in combination with biomaterials, while novel drugs or molecules loaded into exosomes as carriers targeting wound cells will be development trends. Keywords: diabetic wound, mesenchymal stem cell, exosome, biomaterial Diabetes is recognized globally as one of the major health events. According to "2021IDF Global Diabetes Map (10th edition)", the worldwide number of adults with diabetes reached 537 million (10.5%) in 2021, increasing by 16% compared to that of 2019. The harm of diabetes mainly exhibits in its complications, among which unhealed diabetic wounds may lead to lower limb amputation, consuming 20–40% of medical resources per year. 1 Since traditional therapy like debridement and wound dressing has little effect, new treatments for diabetic wounds have emerged, such as bioengineered skin substitutes, hyperbaric oxygen therapy, electrical stimulation pulse therapy, stem cell therapy, and so on. 2 Among them, stem cells have been widely studied because of their pluripotency, self-renewal, and ability to promote the secretion of regenerative cytokines. Many studies have confirmed that pluripotent stem cells, especially MSCs or some omnipotent progenitor cells, promote diabetic wound healing, 3 with exosomes formed and released by stem cells as a critical part of the healing process. 4 Exosomes derived from MSCs can transport genetic material and transcription factors to regulate recipient cells and mediate cellular crosstalk among macrophages, endothelial cells (ECs), and fibroblasts. 5 More importantly, cell-free therapy has a rare risk of cancer compared to stem cell therapy. Therefore, cell-free therapy with exosomes has become a hot spot regarding diabetic wound healing. 6 Due to the heterogeneity of MSCs derived from different tissues, the contents of exosomes may differ from each other, so as do the roles in diabetic wound healing. In addition, methods of extracting MSCs vary from tissue to tissue, and there are different contents in various exosomes, like long non-coding RNA (lncRNA), microRNA (miR), and circular RNA (circRNA). Therefore, it is logical and systematic to classify MSCs by this method. We use the search query combination "(exosomes [Title/]) AND (diabetes wound) AND (stem cell)" to search literature in 2015–2022 from PubMed, Web of Science, Embase, and so on. After the screening, we selected about 60 articles for the main part of our review, the majority of which are original research articles. This review will compare the effects of exosomes, which take several kinds of contents, derived from different MSCs on diabetic wound healing, and briefly introduce the related technologies of exosome biomaterials (Figure 1). Figure 1 Mechanism of exosomes targeting cells on diabetic wounds with different contents or being combined with biomaterials Exosomes with different contents or pretreatment secreted from MSCs act on repair-related cells in diabetic wounds through some signaling pathways such as PTEN/PI3K/AKT, TLR4/NF-KB/STAT3/AKT, SIRT3/SOD2, to promote wound healing by macrophage M2 polarization, endothelial cell proliferation, fibroblast proliferation and migration, collagen deposition, etc. Exosomes and biomaterials can be used in combination to serve the same purpose in diabetic wounds. The figure was partly gen -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology